Skip to content
The Nexus
BUSINESSJul 21 · 12:00 UTCQUARTZCris Tolomia

Novo Nordisk is suing Eli Lilly over ads it says mislead consumers on weight loss drug efficacy

Novo Nordisk is suing Eli Lilly, alleging that its TV and social media advertisements use outdated trial data to mislead consumers about the efficacy of weight loss drugs Zepbound and Mounjaro compared to rival injections.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Novo NordiskorganizationEli LillyorganizationZepboundtopicMounjarotopicweight loss drugstopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting